Enhancing the patient experience in clinical trials How adaptable DCT models, purpose-built eCOA technology, and intentional engagement strategies can improve retention and increase efficiency



Tuesday, November 9, 2021 11 am EST | 8am PST | 5pm CET | 4pm GMT Learn how to strengthen patient engagement, improve data quality, and drive greater efficiency in your next clinical trial using decentralized clinical trials tools and eCOA.

Register free: https://www.appliedclinicaltrialsonline.com/act_w/experience

Event overview:

Today’s complex protocols and competing trials compound the challenges to recruiting and retaining qualified participants. Sponsors need innovative solutions that seamlessly integrate data, proven DCT operations models, and advanced technologies to improve trial experience.

In this webinar, IQVIA experts will share how to develop intentional patient engagement strategies using decentralized approaches including fit-for-purpose electronic Clinical Outcome Assessment (eCOA) tools, eConsent and more. The result? Strengthened patient engagement, improved data quality, and greater efficiency.

3 Key take-aways

Join this timely webinar, and walk away better equipped to:

  • Deliver on the demand for faster, patient-centric trials by giving study participants more control over their trial experience with technology solutions
  • Design decentralized trials based on patients’ daily lives, preferences and needs in mind
  • Accelerate seamless data collection while reducing the burden of trial participation by purposefully deploying electronic Clinical Outcome Assessment (eCOA)


Katy Preciado
Decentralized Clinical Trials Solutions Director

Katy Preciado is the Decentralized Clinical Trials Solutions Director at IQVIA, where she managed DCT trials across phases I-IV and indications, including dermatology, infectious diseases/vaccines, oncology and CNS. With over 12 years of experience in the clinical research industry, Katy was a founding member of one of the first US DCT companies and joined IQVIA in 2019, and soon after took over an extensive portfolio of COVID treatment trials and COVID-mitigation trials utilizing decentralized capabilities. Katy received her Master of Public Health in research epidemiology from Loma Linda University.

Anthony Mikulaschek
eCOA Operations Lead

As senior director of eCOA operations at IQVIA, Anthony Mikulaschek manages all operations, data management, quality management, training and eCOA project work associated with IQVIA eCOA. Anthony has extensive experience in validated system implementation, systems integration, business process reengineering, IT operations, and consulting. He has successfully led the development, delivery, and management of technology solutions for over 30 years including 26 years in the Pharmaceutical sector.

Melissa Easy
Vice President, Clinical Technologies, IQVIA R&D Solutions

Melissa Easy is Vice President of R&D Technologies at IQVIA, responsible for the strategy, delivery and development of technology portfolio and technology-enabled services that improve clinical trial delivery for IQVIA and customer clinical trials more efficiently. She believes we must take advantage of orchestrated technology to bring patients, sites, and sponsors together in a concerted effort to save time, money, and lives. Melissa is a frequent speaker in the industry and has received many awards including PharmaVoice 100 and most recently being named an HBA Luminary.

Register free https://www.appliedclinicaltrialsonline.com/act_w/experience

Related Content
© 2024 MJH Life Sciences

All rights reserved.